Ongoing
Closed
Multicenter, randomized, double-blind, parallel-group, placebo-controlled study with an open-label period to evaluate the efficacy and safety of fremanezumab for the prophylactic treatment of migraine in patients with inadequate response to previous preventive treatments
Wed 9 May, 2018
Pharmacogenomics for predicting liver toxicity in multiple sclerosis patients treated with interferon beta
Mon Jan 1, 2018
Effect of calcifediol on seizure control in pharmacologically treated adult patients with epilepsy (EPID2020)
Fri 1th Sep 2017. p.m. CEST
A Prospective, Non-Interventional, Observational, Multicenter Study to Investigate Dosage, Effectiveness, and Safety of Perampanel when Used as First Adjunctive Therapy in the Routine Clinical Care of Subjects ≥12 Years with Partial Onset Seizures With or Without Secondary Generalization or with Primary Generalized Tonic–Clonic Seizures Associated with Idiopathic Generalized Epilepsy. Study E2007-M044-512
Fri 1th Sep 2017. p.m. CEST
